Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Masato Okada

Showing results (351-360 of 443) with videos related to

Pageof 45
Sort By:
Modern Rheumatology|May 2, 2025
Pearls and pitfalls in imaging of axial spondyloarthritis for rheumatologistsTaiki Nozaki, Yuko Tsujioka, Hideharu Sugimoto, et al.
Rheumatology and Therapy|October 28, 2021
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2HLars-Erik Kristensen, Masato Okada, William Tillett, et al.
International Journal of Cardiology. Heart & Vasculature|August 4, 2020
Early recurrence during the blanking period and left atrial reverse remodeling after catheter ablation for non-paroxysmal atrial fibrillationTakafumi Oka, Yasushi Koyama, Koji Tanaka, et al.
Modern Rheumatology|January 13, 2025
Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 studyYoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
The Journal of Rheumatology|December 17, 2017
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)Désirée van der Heijde, Dafna D Gladman, Mitsumasa Kishimoto, et al.
Frontiers in Behavioral Neuroscience|February 13, 2025
Differences in category information processing between areas TEO and TE of the macaqueMasaumi Shimizu, Shun Katakami, Masato Okada, et al.
The Journal of Biological Chemistry|April 4, 2013
Identification of a new interaction mode between the Src homology 2 domain of C-terminal Src kinase (Csk) and Csk-binding protein/phosphoprotein associated with glycosphingolipid microdomainsHiroaki Tanaka, Ken-ichi Akagi, Chitose Oneyama, et al.
Clinical and Experimental Rheumatology|July 12, 2021
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised studyHiroaki Matsuno, Young Mo Kang, Masato Okada, et al.
The Journal of Cell Biology|April 6, 2016
P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistanceAri Hashimoto, Tsukasa Oikawa, Shigeru Hashimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 30, 2018
Efficacy and Safety of Figure-of-Eight Suture for Hemostasis After Radiofrequency Catheter Ablation for Atrial FibrillationMasato Okada, Koichi Inoue, Koji Tanaka, et al.
Pageof 45

Showing results (351-360 of 443) with videos related to

Sort By:
Pageof 45
Modern Rheumatology|May 2, 2025
Pearls and pitfalls in imaging of axial spondyloarthritis for rheumatologistsTaiki Nozaki, Yuko Tsujioka, Hideharu Sugimoto, et al.
Rheumatology and Therapy|October 28, 2021
Ixekizumab Demonstrates Consistent Efficacy Versus Adalimumab in Biologic Disease-Modifying Anti-rheumatic Drug-Naïve Psoriatic Arthritis Patients Regardless of Psoriasis Severity: 52-Week Post Hoc Results from SPIRIT-H2HLars-Erik Kristensen, Masato Okada, William Tillett, et al.
International Journal of Cardiology. Heart & Vasculature|August 4, 2020
Early recurrence during the blanking period and left atrial reverse remodeling after catheter ablation for non-paroxysmal atrial fibrillationTakafumi Oka, Yasushi Koyama, Koji Tanaka, et al.
Modern Rheumatology|January 13, 2025
Disease activity and glucocorticoid tapering patterns in Japanese patients with systemic lupus erythematosus treated with anifrolumab: Post hoc analysis of the Japanese subpopulation of the TULIP-2 studyYoshiya Tanaka, Tatsuya Atsumi, Masato Okada, et al.
The Journal of Rheumatology|December 17, 2017
Efficacy and Safety of Ixekizumab in Patients with Active Psoriatic Arthritis: 52-week Results from a Phase III Study (SPIRIT-P1)Désirée van der Heijde, Dafna D Gladman, Mitsumasa Kishimoto, et al.
Frontiers in Behavioral Neuroscience|February 13, 2025
Differences in category information processing between areas TEO and TE of the macaqueMasaumi Shimizu, Shun Katakami, Masato Okada, et al.
The Journal of Biological Chemistry|April 4, 2013
Identification of a new interaction mode between the Src homology 2 domain of C-terminal Src kinase (Csk) and Csk-binding protein/phosphoprotein associated with glycosphingolipid microdomainsHiroaki Tanaka, Ken-ichi Akagi, Chitose Oneyama, et al.
Clinical and Experimental Rheumatology|July 12, 2021
Comparison of the efficacy and safety of LBAL, a candidate adalimumab biosimilar, and adalimumab reference product in patients with active rheumatoid arthritis inadequately responding to methotrexate: a 52-week phase III randomised studyHiroaki Matsuno, Young Mo Kang, Masato Okada, et al.
The Journal of Cell Biology|April 6, 2016
P53- and mevalonate pathway-driven malignancies require Arf6 for metastasis and drug resistanceAri Hashimoto, Tsukasa Oikawa, Shigeru Hashimoto, et al.
Circulation Journal : Official Journal of the Japanese Circulation Society|January 30, 2018
Efficacy and Safety of Figure-of-Eight Suture for Hemostasis After Radiofrequency Catheter Ablation for Atrial FibrillationMasato Okada, Koichi Inoue, Koji Tanaka, et al.
Pageof 45